Correction to: Oncogene (2017) 36, 4802–4809; doi:10.1038/onc.2017.21; published online 13 March 2017
Since the publication of the above article the authors have noticed that the siRNA DUB3 oligonucleotide sequence mentioned in the article is incorrect. The correct sequence of the DUB3 siRNA oligo is GGAGAUCCAAAGGGAAGAAdTdT.
The authors apologize for any inconvenience caused by this error.
This error has now been rectified. The html and online pdf versions have also been rectified, and now carry the corrected paper.
Additional information
The online version of the original article can be found at 10.1038/onc.2017.21
Rights and permissions
About this article
Cite this article
Hernández-Pérez, S., Cabrera, E., Salido, E. et al. Erratum: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer. Oncogene 36, 4817 (2017). https://doi.org/10.1038/onc.2017.220
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2017.220
This article is cited by
-
Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner
Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
-
DNA replication fork speed underlies cell fate changes and promotes reprogramming
Nature Genetics (2022)
-
The equilibrium of tumor suppression: DUBs as active regulators of PTEN
Experimental & Molecular Medicine (2022)
-
Digital spatial profiling application in breast cancer: a user’s perspective
Virchows Archiv (2020)
-
USP7 Regulates Cytokinesis through FBXO38 and KIF20B
Scientific Reports (2019)
